Latuda
Total Payments
$2.2M
Transactions
1,172
Doctors
54
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $18,129 | 22 | 3 |
| 2023 | $30,794 | 33 | 4 |
| 2022 | $45,643 | 42 | 4 |
| 2021 | $39,155 | 22 | 12 |
| 2020 | $27,510 | 23 | 4 |
| 2019 | $1.4M | 265 | 4 |
| 2018 | $340,728 | 739 | 37 |
| 2017 | $261,295 | 26 | 6 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 895 | 78.2% |
| Consulting Fee | $289,408 | 43 | 13.1% |
| Honoraria | $81,704 | 27 | 3.7% |
| Travel and Lodging | $59,762 | 93 | 2.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,630 | 12 | 2.0% |
| Food and Beverage | $4,184 | 53 | 0.2% |
| Education | $2,745 | 49 | 0.1% |
Payments by Type
Research
$1.7M
895 transactions
General
$482,433
277 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Pediatric Open-Label Extension Study | Sunovion Pharmaceuticals Inc. | $1.5M | 4 |
| psychiatric research | Sumitomo Dainippon Pharma Co., Ltd. | $210,000 | 1 |
| Lurasidone Pediatric Bipolar Study | Sunovion Pharmaceuticals Inc. | $3,717 | 0 |
Top Doctors Receiving Payments for Latuda — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Child & Adolescent Psychiatry | Cleveland, OH | $60.80 | 1 |
| , MD | Psychiatry | New York, NY | $60.80 | 1 |
| , M.D | Psychosomatic Medicine | Honolulu, HI | $60.80 | 1 |
| , M.D | Psychiatry | Baltimore, MD | $60.80 | 1 |
| , M.D | Psychiatry | Rock Hill, SC | $60.80 | 1 |
| , MD | Psychiatry | Riverside, CA | $60.80 | 1 |
| , DO | Psychiatry | Boca Raton, FL | $59.30 | 1 |
| , M.D | Psychiatry | Boston, MA | $59.30 | 1 |
| , M.D | Psychiatry | Palo Alto, CA | $52.30 | 1 |
| , MD | Psychiatry | Long Beach, CA | $52.30 | 1 |
| , MD | Psychiatry | Virginia Beach, VA | $52.30 | 1 |
| , MD | Family Medicine | Powhatan, VA | $52.30 | 1 |
| , MD | Psychiatry | Chesapeake, VA | $52.30 | 1 |
| , MD | Psychiatry | North Myrtle Beach, SC | $52.30 | 1 |
| , M.D | Psychiatry | Menlo Park, CA | $52.30 | 1 |
| , MD | Psychiatry | Goldsboro, NC | $52.30 | 1 |
| , CNS | Psychiatric/Mental Health | Fort Wayne, IN | $52.30 | 1 |
| , M.D | Psychiatry | Kingston, NC | $52.30 | 1 |
| , M.D | Psychiatry | Greenville, SC | $52.30 | 1 |
| , MD | Internal Medicine | Greensboro, NC | $52.30 | 1 |
| , MD | Psychiatry | Jacksonville, FL | $52.30 | 1 |
| , MD | Psychiatry | Charleston, SC | $52.30 | 1 |
| , M.D | Psychiatry | Asheboro, NC | $52.30 | 1 |
| , M.D | Psychiatry | Winston Salem, NC | $52.30 | 1 |
| , M.D | Psychiatry | Riverside, CA | $52.30 | 1 |
Ad
Manufacturing Companies
- Sunovion Pharmaceuticals Inc. $1.8M
- Sumitomo Dainippon Pharma Co., Ltd. $333,770
- Sumitomo Pharma Co., Ltd. $94,521
Product Information
- Type Drug
- Total Payments $2.2M
- Total Doctors 54
- Transactions 1,172
About Latuda
Latuda is a drug associated with $2.2M in payments to 54 healthcare providers, recorded across 1,172 transactions in the CMS Open Payments database. The primary manufacturer is Sunovion Pharmaceuticals Inc..
Payment data is available from 2017 to 2024. In 2024, $18,129 was paid across 22 transactions to 3 doctors.
The most common payment nature for Latuda is "Unspecified" ($1.7M, 78.2% of total).
Latuda is associated with 3 research studies, including "Pediatric Open-Label Extension Study" ($1.5M).